INTRODUCTION {#sec1-1}
============

*Cassia sieberiana* (D.C.) belongs to the Family; Caesalpiniaceae Leguminosae, common name; African laburnum also called "Malga" in Hausa language, is a common plant in Saharan and sub-Saharan Africa. It is a savannah tree found in the dry areas of the forest and thickets \[[@ref1]\]. It is often part of remedies in African veterinary and human therapies \[[@ref2]-[@ref4]\] particularly in north eastern and north western Nigeria where it is used for treatment of malaria, inflammatory conditions, rheumatism, jaundice, diarrhea, deworming, and aphrodisiacs \[[@ref5]\]. The herb is usually available, affordable and acceptable to most of the consumers \[[@ref6]\].

One of the major public health problems and greatest health challenges faced by 40% of the world's population is the malaria disease, which is caused by *Plasmodium* species, and transmitted by the bite of female Anopheles mosquito. The disease has caused much suffering and premature death in the poorer region of tropics and subtropics \[[@ref7]\]. It has been estimated that 1.2 billion population are at high risk of transmission (≥1 case per 1000 population), and half of these population live in the African region; of which 80% cases are strenuous in 13 countries, and over half in Nigeria, Congo, Tanzania, Kenya, and Ethiopia. A quarter of all malaria cases in Africa, is presented in Nigeria where disease transmission occurs all year round in the southern part of the country and seasonal in the north \[[@ref8]\]. At present, the still leading Africa's health problem is malaria, this occurs due to drug resistance to most anti-malarial drugs, insecticide resistance, war and civil disturbances, climatic changes, environmental changes, population increase and travel \[[@ref8]\].

Therefore, the search for new anti-malarial compounds, either synthetic or natural is important for the killing of either the vector or parasite \[[@ref9]\]. The use of plant-derived drugs for the treatment of malaria has a long and successful tradition \[[@ref10],[@ref11]\]. For example, in the 1950's quinine was isolated from Cinchona and artemisinin from quinghaosu \[[@ref12]\]. This illustrates the potential value of investigating traditionally used anti-malarial plants for developing pharmaceutical anti-malarial drugs \[[@ref13]\]. Unfortunately, chloroquine resistance now occurs throughout the whole world \[[@ref14]\].

Certainly, native plants play an important role in the treatment of many diseases and 80% of people worldwide have been estimated to use herbal remedies \[[@ref15]\]. However, information obtained on efficiency and safety of herbal use is few, despite the fact that motives of traditional practices could lead to novel strategies in malaria control. Different types of African plants used by traditional healers to treat and cure malaria symptoms have already been tested \[[@ref16]\]. The increased number of drug-resistant malaria parasites, such as chloroquine-resistant malaria parasite has made the development of novel antimalarials urgent, and the high cost of malaria treatment has left the poor masses of Nigeria heavily reliant on traditional practitioners and medicinal plants for the treatment of the disease. For this study, the investigations on rodent malaria models for the antimalarial activity of *C. sieberiana* was carried out to verify the use experientially of the root and stem plant parts as ingredients in the traditional remedies for the treatment of malaria in aboriginal Northern Nigeria. With this view, the present study was executed to provide scientific evidence of its efficacy and continuous use in ethno therapeutic management of malaria.

METHODOLOGY {#sec1-2}
===========

This study evaluates the in vivo antiplasmodial effect of ethanolic extract of *C. sieberiana* on mice. Stem bark and root of *C. sieberiana* were collected from Dundaye village of Usmanu Danfodiyo University, Sokoto State, Nigeria. The plant was identified and botanically authenticated at the herbarium unit, Department of Pharmacognosy Faculty of Pharmaceutical Sciences, Usmanu Danfodiyo University, Sokoto, Nigeria. A voucher specimen (pcg/udus/caes/0010) was prepared and deposited for future reference at the Pharmacognosy herbarium unit, Usmanu Danfodiyo University Sokoto. The root and stem samples were cleaned, air-dried and pounded into a fine powder using mortar and pestle. The powder was then stored in a dry air-tight container. Extraction was carried using soxhlet apparatus. The soxhlet method of extraction \[[@ref17]\] was employed in extracting the plant material using ethanol. The extraction was carried out by placing 400 g of each of the powdered plant part in the upper chamber in a trimble and 700 ml of the solvent in the bottom of the flask. After the plant was extracted, the vapor was condensed to extract the sample to dryness using steam evaporator to obtain the crude extract of the plant. The dried ethanol crude extracts were weighed and stored in the refrigerator at 4°C in airtight plastic container until use for this study. The extracts were weighed and dissolved in distilled water for preparation of appropriate doses on each day of the experiment.

Phytochemicals Screening {#sec2-1}
------------------------

A combination of several methods was used to identify the phytochemicals of the root and stem part. Standard screening tests using conventional protocol, procedure and reagents were used for detecting the major secondary metabolites present in the plant \[[@ref18]\].

Experimental Animal {#sec2-2}
-------------------

Sixty two mice of both sexes of Swiss Albino mice having body weight of 16-33 g, were obtained from Laboratory Animal Housing Unit of National Veterinary Research Institute (NVRI), VOM, Jos. They were kept at the Animal Housing Unit of the Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Usmanu Danfodiyo University, Sokoto, Nigeria. The consent of the ethical committee was obtained from the veterinary research and ethical committee on the use of Laboratory animal for research purposes of Usmanu Danfodiyo University Sokoto, Nigeria. The animals were housed in standard cages for 5 days prior to dosing to allow for acclimatization to the laboratory conditions in accordance with the National Institute of Health guideline for the care and use of Laboratory animals \[[@ref18]\].

Rodent Parasite Used {#sec2-3}
--------------------

The rodent parasite *Plasmodium berghei* NK 65 inoculated in four donor mice was sourced from the Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Research and Development (NIPRD), Idu Abuja, Nigeria, and were kept at the Animal housing unit of the Department of Phamarcology and Toxicology, Faculty of Veterinary Medicine, Usmanu Danfodiyo University, Sokoto, Nigeria. Prior to commencing the study, four of the infected mice (donor mice) were kept and observed to reproduce disease symptoms similar to malarial human infection \[[@ref19]\]. The donor mice (parasitaemia of about 20-30%) were anesthetized with chloroform, and their infected blood were collected via cardiac puncture with a pre-heparinized sterile syringe and needle. To avoid variability in parasitemia, the blood collected was pooled together. The collected blood was then diluted with 0.9% physiological saline, and the dilution was made based on the parasitemia of the donor mice and the red blood cell (RBC) count of averagely healthy mice (4.5×10^9^ RBC/ml) \[[@ref20]\] in such a way that 0.2 ml of blood contains 1×10^7^ infected erythrocytes. Each mouse was administered intra-peritoneally with 0.2 ml of this diluted blood, which contains 1×10^7^ *P. berghei* infected erythrocytes. The parasites were kept alive by continuous intra-peritoneal passage in mice every four days, and the re-infected mice were used for the study \[[@ref21]\].

Acute Toxicity Studies {#sec2-4}
----------------------

Acute toxicity of *C. sieberiana* ethanolic root and stem bark extract was carried out using up and down procedure to test the oral acute toxicity on two groups of five female mice which were selected at random and marked to permit individual identification. To conduct the limit test, food (excluding water) was withheld from the mice for 3 h. The fasted body weight of each animal was determined, and the dose was calculated according to the body weight. Water extract of crude extract of the leaves and fruits was administered orally in concentrations of 2000 mg/kg, body weights dose to five groups of animals (each consisting of one animal) using a stomach tube one after the other at the grace observation period of 24 h, 48 h and up to 14 days in a single oral dose while the control group received distilled water only. After the substance has been administered, food was withheld for a further 3-4 h and observation of toxic symptoms was made and recorded systematically at 1, 2, 4 and 6 h after administration. Finally, the number of death and survivors was noted after 24 h, 48 h and up to 14 days for each animal. The dosed mice were observed for the first 1, 2, 4 and 6 h after administration and intermittently for the next 24 h for signs of toxicity. The second mouse was dosed at 24 h interval until all five mice were dosed. The control group received distilled water only. And all five mice were observed thereafter for the next fourteen days for any delayed toxic effect. Observation of toxic symptoms was made and recorded systematically at 1, 2, 4 and 6 h after administration. Finally, the number of death and survivors was noted after 24 h, 48 h and up to 14 days for each animal. The toxicological effect was assessed on the basis of toxicity sign: paw licking, salivation, stretching of the entire body, weakness, sleep, respiratory distress, tremor, off-feed, depression coma and mortality, which were expressed as lethal doze 50 (LD~50~) \[[@ref22]\].

Anti-plasmodial Analysis {#sec2-5}
------------------------

The Peter's 4-day suppressive test against Chloroquine sensitive *P. berghei* (NK 65) infection in mice was employed \[[@ref23]\]. Twenty albino mice of both sexes were inoculated. They were randomly grouped with the same number of male and female and four mice in each group. The animal were then administered extract daily for 4 consecutive days. On day 1 (D~0~); heparinized blood was prepared from the donor mouse as explained earlier, treatment started 2 h after the mice were infected with the parasite. Group 1 that served as control was orally administered with 1 ml/kg body weight of normal saline, Groups 2, 3 and 4 were orally administered with 100, 200 and 300 mg extract/kg body weight daily respectively, while group 5 was administered with 5 mg chloroquine/kg body weight orally \[[@ref23]\]. On Day 2-4 (D~1~-D~3~); the mice were treated again with the same doses and through the same route as in D~0~ at interval of 24 h, 48 h and 72 h post-infection \[[@ref24]\]. On the 5th day (D~4~), blood was collected from the tail of each mouse and spread on a microscope slide to make a thin film. The blood films were fixed with methanol for 1 min stained with 3% Giemsa solution for 30 min and examined microscopically \[[@ref25]\]. Eight fields containing 250 erythrocyte and the number of parasitized erythrocytes were recorded while the suppression of parasitemia was expressed as percent for each dose, by comparing the parasitemia in the control group with the treated one. The mice were observed for signs of toxicity after treatment for the first 4 (critical) h, then over a period of 24 h, thereafter daily for 7 days. Mortality occurring at a particular dose will indicate either to continue administration of subsequent higher dose or to estimate the LD~50~ by comparing the mortality to a fixed LD~50~ cut-off values provided in the guideline \[[@ref26]\].

Data Analysis {#sec2-6}
-------------

Results were expressed as mean ± standard error of the mean. The data obtained were entered and analyzed using Analyze-it version 2.22 Excel 12+ statistical package. Chi-square test at a 95% confidence level was used to compare the result and values of *P* \< 0.05 were considered as statistically significance.

RESULTS {#sec1-3}
=======

The results obtained showed significant decrease in parasitaemia of *P*. *berghei* infected mice treated with the ethanolic root and bark extract of *C. sieberiana* \[Tables [1](#T1){ref-type="table"} and [2\]](#T2){ref-type="table"}. This significant suppression of parasitaemia observed was dose dependent (*P* \< 0.05). The crude root extract (300 mg/kg) caused 55.8% suppression and the crude stem extract (300 mg/kg) caused 63.9% suppression in parasitaemia of *P. berghei* infected mice while chloroquine a standard antimalarial drug (5 mg/kg) exerted 96% suppression.

###### 

Antiplasmodial suppressive test of ethanolic root extract of *C. sieberiana* (suppressive test on *P. berghei*)
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###### 

Antiplasmodial suppressive test of ethanolic stem extract of *C. sieberiana* (suppressive test on *P. berghei*)

![](JIE-4-96-g002)

The oral median LD~50~ of the extract was estimated to be ≥2000 mg/kg in mice. There were no remarkable behavioral changes in the extract administered mice (reaction to food supply, contact and noise), though activity was reduced in some of the extract administered groups within the first 4 h. And no mortality occurred within the observation period of 14 days. However, behavioral signs of toxicity were observed in mice given 2000 mg stem extract/kg body weight which include; paw licking, salivation, stretching and reduced activity. There was however no mortality at all the dose levels used. And the oral median LD~50~ was estimated to be ≥2000 mg extract/kg body weight \[Tables [3](#T3){ref-type="table"} and [4](#T4){ref-type="table"}\].

###### 

Acute toxicity study of ethanolic root extract of *C. sieberiana*
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###### 

Acute toxicity study of ethanolic root extract of *C. sieberiana*
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The result from the phytochemical analysis of ethanolic root bark extract of *C. sieberiana* showed; high amount of Carbohydrates using Molisch's test, high amount of Reducing Sugars using Fehling's test, high amount of Tanins using Ferric chloride test, Lead Actate test and Bromine water test, high amount of Flavonoids using Sulfuric acid test and Ferric chloride test, high amount of Saponins using Frothing test, high amount of Steroids and Triterpenoid using Liebermann--Buchard test and Salkowaski test, and also high amount of Cardiac Glycosides using Keller-Kiliani's test, using Borntrager's test Anthraquinones was in moderate amount while using Dragendorff's test and Wagner's test Alkaloids scored low \[[Table 5](#T5){ref-type="table"}\]. The ethanolic stem bark extract of *C. sieberiana* indicated; high amount of flavonoids in Sulfuric acid test and Ferric chloride test, high amount high amount of reducing sugars in Fehling's test, high amount of carbohydrates in Molisch's test, high amount of cardiac glycosides in Keller-Kiliani's test, high amount of tannins in Ferric chloride test, Lead Actate test and Bromine water test, in Salkowaski's test, Steroids and Triterpenoids were high but in Liebermann--Buchards test they were both low, there was moderate amount of Antraquinones in Borntrager's test and Saponins and Alkaloids were low using Frothing's test, Dragendorff's test and Wagner's, respectively \[[Table 6](#T6){ref-type="table"}\].
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Phytochemical analysis of ethanolic root extract of *C. sieberiana*
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###### 

Phytochemical analysis of ethanolic stem extract of *C. sieberiana*
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DISCUSSION {#sec1-4}
==========

The four-day suppressive test which is a standard test commonly used for antimalarial screening and determination of percentage inhibition of parasitaemia in laboratory animal as used in this study indicated a mean group parasitaemia level of less than or equal to 96% of the mock-treated control animals given a suggestion that the test material is active in standard screening studies \[[@ref23]\]. It has been reported that when a standard antimalarial drug is used on mice infected with *P*. *berghei*, it suppresses parasitaemia to non-detectable levels \[[@ref27]\]. The observed antimalarial activity is consistent with the traditional use of the plant as an herbal medication against the disease in Nigeria. The extracts exerted significantly repository effect in mice treated with 100, 200 and 300 mg/kg body weight respectively \[Tables [3](#T3){ref-type="table"} and [4](#T4){ref-type="table"}\]. This effect was however lower in groups that received low dose. This effect may be due to short duration of action of the extract occasioned by rapid metabolism, and so parasite clearance could not be total. It may also be explained by the fact that not all anti-malarials are completely active against *P. berghei* model \[[@ref28]\]. The rodent model of malaria that was employed in this study for prediction of efficacy of anti-malarial effect of *C. sieberiana* root and stem bark extract, was also used for conventional antimalarial agents such as chloroquine, halofantrine, mefloquine and more recently artemisinin derivatives \[[@ref29]\]. *P. berghei* are used in the prediction of treatment outcomes. Hence it was an appropriate parasite for the study. Since this parasite was sensitive to chloroquine, this drug was used as the standard drug in this study. The choice of 4 weeks old male mice for the study was done to avoid the effect of anemia in the old mice and the effect of possible physiological changes associated with ageing and gender may induce on the treatment outcome \[[@ref30]\]. An *in vivo* model was employed for this study because it takes into account possible prodrugs effect and possible involvement of the immune system in eradication of infection \[[@ref20]\]. Certain compounds form the basis of the pharmacologic effects of such plants \[[@ref31],[@ref32]\]. Presence of alkaloids ranks among the most efficient and therapeutically significant plant compounds, moreover pure alkaloids and their synthetic derivatives are used as basic medicinal agents e.g. morphine is an analgesic, quinine is antiplasmodial, colchicines is used for gout, reserpine is a tranquilizer, vincristine and vinblastine have antitumor effects \[[@ref31]\], terpenes, anthraquinones, and flavonoids screened plants has been implicated in antiplasmodial activity \[[@ref33],[@ref34]\]. Earlier studies \[[@ref35]\], reported the oxidant generation potential of *Acacia nilotica* extract, based on the ability of the extract to increase conversion of reduced glutathione to oxidized glutathione. Increased oxidation has also been shown to create an intracellular environment that is unfavorable to plasmodial growth \[[@ref36],[@ref37]\]. The mechanism of action of artemisinin, which depends on oxidant action for its potent antimalarial activity, validates this \[[@ref35]\]. However, lack of oxidizing action in some plants does not rule out anti plasmodial activity since they may be active through other biochemical mechanisms. The oral median LD of ≥3000 mg/kg body weight obtained for the Ethanolic root and stem bark extract of *C. sieberiana* DC is 31 times greater than the minimum effective dose of 100 mg/kg. Earlier reports have shown that if the median LD of a test substance is three times more than the minimum effective dose, the substance is considered a good candidate for further studies. It was also reported that oral administration is about 100 times less toxic than the intra-peritonial \[[@ref38]\]. These findings suggested that the extract could be safe, and this partly explain the safe use of the plant by the local people who have been using it in traditional management of malaria in Nigeria.

CONCLUSIONS {#sec1-5}
===========

It is evident based on these findings that *C. sieberiana* possess potent anti-plasmodial effect justifying its folkloric usage in the management of anti-malarial. However, the active principle(s) are yet to be identified, and there is a need for the identification. In view of this fact, attempts are being made to carry out anti-plasmodial curative test, prophylactic test as well as guided fractionation of the root and stem ethanolic extract to isolate the active compounds and also to test for the cytotoxicity of the extract.
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